CTS - CTS Corporation
| Previous Close | 29.79 |
| Open | 29.80 |
| Bid | 29.75 x 1400 |
| Ask | 29.92 x 800 |
| Day's Range | 29.48 - 29.85 |
| 52 Week Range | 25.05 - 39.20 |
| Volume | 8,589 |
| Avg. Volume | 151,206 |
| Market Cap | 982.684M |
| Beta (3Y Monthly) | 1.08 |
| PE Ratio (TTM) | 67.19 |
| EPS (TTM) | 0.44 |
| Earnings Date | Oct 25, 2018 |
| Forward Dividend & Yield | 0.16 (0.54%) |
| Ex-Dividend Date | 2018-09-27 |
| 1y Target Est | 37.00 |
- GlobeNewswire•4 days ago
CTS Corporation Announces Dates for Third Quarter 2018 Earnings Release and Conference Call
LISLE, Ill., Oct. 15, 2018 -- CTS Corporation (NYSE: CTS) will release earnings for the third quarter 2018 at approximately 8:00 a.m. (EDT) on Thursday, October 25, 2018. A.
- Simply Wall St.•6 days ago
Will CTS Corporation (NYSE:CTS) Continue To Underperform Its Industry?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...
- Zacks•last month
Electronics Components Outlook: Growth Inherent Amid Trade Spat
Electronics Components Outlook: Growth Inherent Amid Trade Spat
- GlobeNewswire•last month
CTS to Present at the Sidoti & Company Fall 2018 Conference
LISLE, Ill., Sept. 17, 2018-- CTS Corporation will be presenting at the Sidoti & Company Fall 2018 Conference on September 27, 2018 at 9:45 a.m. at the New York City Grand Hyatt. Additional information ...
- Simply Wall St.•last month
Is CTS Corporation’s (NYSE:CTS) Balance Sheet Strong Enough To Weather A Storm?
Investors are always looking for growth in small-cap stocks like CTS Corporation (NYSE:CTS), with a market cap of US$1.20b. However, an important fact which most ignore is: how financially healthyRead More...
- GlobeNewswire•2 months ago
New Research: Key Drivers of Growth for REGENXBIO, Syndax Pharmaceuticals, Rowan Companies, CTS, Basic Energy Services, and Impinj — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Aug. 27, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of REGENXBIO ...
- GlobeNewswire•2 months ago
CTS Corporation Declares a Dividend
LISLE, Ill., Aug. 23, 2018-- The Board of Directors of CTS Corporation declared a cash dividend of $0.04 per share, payable November 2, 2018, to shareholders of record at the close of business on September ...
- Thomson Reuters StreetEvents•3 months ago
Edited Transcript of CTS earnings conference call or presentation 26-Jul-18 3:00pm GMT
Q2 2018 CTS Corp Earnings Call
- Associated Press•3 months ago
CTS: 2Q Earnings Snapshot
On a per-share basis, the Lisle, Illinois-based company said it had profit of 21 cents. Earnings, adjusted for non-recurring costs and pretax expenses, were 39 cents per share. The electronics manufacturer ...
- GlobeNewswire•3 months ago
CTS Announces Second Quarter 2018 Results
LISLE, Ill., July 26, 2018-- CTS Corporation today announced second quarter 2018 results. Sales were $118.0 million, up 11.7% year-over-year, with organic growth at 10.9%. Sales to transportation customers ...
- PR Newswire•3 months ago
Kodiak Sciences Appoints Bassil I. Dahiyat, Ph.D. Robert A. Profusek, J.D. and Richard S. Levy, M.D. to its Board of Directors
PALO ALTO, Calif., July 18, 2018 /PRNewswire/ -- Kodiak Sciences Inc., a clinical stage biopharmaceutical company specializing in novel therapeutics to treat high prevalence ophthalmic diseases, today announced the appointments of Bassil I. Dahiyat, Ph.D., Robert A. Profusek, J.D., and Richard S. Levy, M.D. to its Board of Directors. Dr. Dahiyat is the co-founder of Xencor (XNCR), a biopharmaceutical company, and has been its President and Chief Executive Officer since the Company's incorporation in August 1997. Dr. Dahiyat is a co-inventor of Xencor's breakthrough XmAb® antibody engineering technology. He has led Xencor in raising over $700 million in public and private financing, creating a diverse portfolio of monoclonal antibody clinical programs for the treatment of life-threatening and debilitating diseases and establishing alliances with leading biopharmaceutical companies that generated over $200 million in upfront payments. Dr. Dahiyat holds a Ph.D. in Chemistry from Caltech and B.S. and M.S.E. degrees in Biomedical Engineering from the Johns Hopkins University. He has co-authored numerous scientific papers in the fields of protein design and drug delivery, is an inventor of 33 US and numerous foreign patents and has received scientific awards from the American Chemical Society, the Controlled Release Society, the Protein Society and Caltech.
- Reuters•4 months ago
BRIEF-CTS International Logistics Signs Strategic Framework Agreement With JD Logistics' Trading Firm
June 28 (Reuters) - CTS International Logistics Corp Ltd : * SAYS IT SIGNS STRATEGIC COOPERATION FRAMEWORK AGREEMENT WITH JD LOGISTICS' TRADING FIRM Source text in Chinese: https://bit.ly/2ICIV9A Further ...
- Simply Wall St.•4 months ago
Is CTS Corporation’s (NYSE:CTS) Balance Sheet Strong Enough To Weather A Storm?
Investors are always looking for growth in small-cap stocks like CTS Corporation (NYSE:CTS), with a market cap of US$1.15b. However, an important fact which most ignore is: how financially healthyRead More...
- Reuters•4 months ago
BRIEF-CTS International Logistics To Set Up In SPV With Partners To Invest In Jingdong Express
June 22 (Reuters) - CTS International Logistics Corp Ltd : * SAYS UNIT PLANS TO INVEST $41.6 MILLION TO SET UP SPV WITH YULONGHE CAPITAL MANAGEMENT, HANJIANG INVESTMENT * SAYS THE SPV WILL INVEST $90 MILLION ...
- Simply Wall St.•4 months ago
Is City Service SE’s (WSE:CTS) Balance Sheet Strong Enough To Weather A Storm?
While small-cap stocks, such as City Service SE (WSE:CTS) with its market cap of ZŁ331.91M, are popular for their explosive growth, investors should also be aware of their balance sheetRead More...
- Simply Wall St.•5 months ago
Should You Be Tempted To Buy City Service SE (WSE:CTS) Because Of Its PE Ratio?
City Service SE (WSE:CTS) trades with a trailing P/E of 13.2x, which is lower than the industry average of 13.3x. While this makes CTS appear like a great stock toRead More...
- Simply Wall St.•5 months ago
Did City Service SE (WSE:CTS) Create Value For Shareholders?
With an ROE of 11.05%, City Service SE (WSE:CTS) outpaced its own industry which delivered a less exciting 10.48% over the past year. While the impressive ratio tells us thatRead More...
- Zacks Small Cap Research•6 months ago
CTS: Organic growth of nearly 11% Y/Y pushed revenue and earnings to new highs. We are increasing our target price to $32 a share.
CTS Corporation's (CTS) first quarter 2018 results were above our estimates due mainly to above average revenue growth of 10.8% organic plus $2.6 million from the Noliac acquisition. Due to the need to preserve expert knowledge from many years of production in Indiana CST spent an above average amount of money in transferring production to Illinois. This had a negative impact on gross margins so gross profit was close to our estimate.
- Thomson Reuters StreetEvents•6 months ago
Edited Transcript of CTS earnings conference call or presentation 26-Apr-18 3:00pm GMT
Q1 2018 CTS Corp Earnings Call
- Associated Press•6 months ago
CTS: 1Q Earnings Snapshot
The Lisle, Illinois-based company said it had net income of 34 cents per share. The electronics manufacturer posted revenue of $113.5 million in the period. CTS expects full-year earnings in the range ...
